Disease Management and Clinical Outcomes, 4(1), 136-141
Many professional women, just like you, come to me feeling frustrated and wondering why their GLP-1 journey isn't mirroring the rapid results they see on social media
I can see that the weight is coming off
NICE NG28 advises considering a GLP-1 receptor agonist in preference to a sulphonylurea when weight loss or avoidance of hypoglycaemia is a priority, though sulphonylureas remain appropriate options in selected patients
Realistic before-and-after results from AOD 9604 are gradual and better when paired with a structured nutrition and training plan
Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes